Definitive Contract 75F40122C00175
Award Date
9/20/22
Potential Completion Date
9/25/23
Potential Value
$53K
Federal Agency
Food and Drug Administration
Awardee
Proimmune, Inc.
Ultimate Awardee
Not listed
NAICS Category
541690 - Other Scientific and Technical Consulting Services
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $79,659.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Proimmune, Inc., a small business. The contract is for a T cell proliferation assay, which is a type of immunology research service. Proimmune has previously provided similar services to the Department of Health and Human Services, including the FDA and National Institutes of Health, such as MHC class II peptide proteomics assays, HLA typing, and analyzing FVIII-derived peptides. The...
This federal contract award is for BIOLOGICAL ANALYSIS SERVICES provided by Proimmune, Inc. (doing business as Proimmune Inc.), a foreign-owned for-profit organization. The contract was set aside for a small business and has a potential value of $128,801.21. The contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) and has a firm fixed-price pricing type. The place of performance is Silver Spring, Maryland. Through past federal contract...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency under the Department of Health and Human Services (HHS), to Proimmune, Inc. The contract, valued at $40,000.00, is for the performance of ex vivo scientific experiments and the delivery of a final report. The contract has a completion date of June 30, 2015 and was awarded on June 25, 2013. The contract is not set aside for any specific business designation. Proimmune, Inc. is a...
This is a $92,322 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Proimmune, Inc., a small business contractor, to provide services to the FDA's Center for Biologics Evaluation and Research (CBER), Office of Division of Plasma Protein Therapeutics' (DPPT) / Hemostasis Branch (HB). The contract is for determining a reliable and comprehensive identification of FVIII-derived peptides to compare processing by antigen presenting cells between wild-type and...
This is a $88,310 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR gene editing services to develop five different induced pluripotent stem (iPS) cell lines expressing fluorescent proteins or HiBiT tags at specific target genes. This is a non-competitive award under...
This federal contract award to Genscript USA Inc., a biotechnology company, is for the provision of laboratory services to detect mutation-reactive T cells in patients with metastatic cancers. The contract was awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services National Institutes of Health, and has a potential value of $250,000.00. This is a follow-on effort to a previous contract awarded in 2017. The contract has no set-aside designation. Under...
This is a $87,442.00 firm fixed price purchase order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs to Proimmune, Inc., a for-profit company specializing in immunology research. The contract is for the allocation of laboratory time and delivery of reports, with a completion date of October 30, 2020. No set-aside was used for this award. Proimmune has previously provided various immunology research services to the Department of Health and...
This federal contract award is for site-directed mutagenesis services (Catalog #GI-M100) provided by Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, MD. The $9,994.40 firm fixed price contract was awarded on September 22, 2010 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). The contract has an ultimate completion date of September 30, 2010 and does not have a set-aside designation. Geneimmune Biotechnology Corp....
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...
The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a $20,591.00 firm fixed-price purchase order to Proteos Inc. for custom protein purification and expression services. The contract has an ultimate completion date of April 17, 2015. Proteos Inc. is a for-profit organization that specializes in producing high-quality recombinant proteins, particularly HIV-related proteins, for federal agencies like the Centers for Disease...